Project Grant HT94252510314
Award Date
5/1/25
Completion Date
4/30/28
Dollars Obligated
$1M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Oklahoma City, OK 73104, USA
Similar Awards
The Project Grant award of $1,000,000.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award will support research conducted by The Feinstein Institutes for Medical Research, a leading non-profit medical research organization, to investigate the neural substrates of fatigue and impaired cognition in individuals with lupus, a condition also known as "lupus brain fog." The research aims to advance...
This Project Grant award of $793,093 was provided by the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), to the Oklahoma Medical Research Foundation (OMRF). The grant aims to define the regulatory landscape of lupus with cardiovascular disease (CVD) comorbidity. Key products and services to be delivered include: Systematic, high-throughput studies in induced pluripotent stem cell-derived macrophages to...
This federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under CFDA program 93.846 Arthritis, Musculoskeletal and Skin Diseases Research provides $715,957 to support research into the mechanisms by which type I interferon promotes the expansion of T peripheral helper (Tph) cells in patients with systemic lupus erythematosus (SLE). The 5-year project, which runs from March 2025 through February 2030, will apply cutting-edge...
This $299,322 Project Grant award, issued by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) federal grant program, supports research on the biology of hydrolyzed C3 in systemic lupus erythematosus (SLE). The principal investigator and awardee is The Washington University, a prominent private research institution located in St. Louis, Missouri. The award period runs from August 1, 2024 to July 31, 2026. The research aims to advance scientific...
This $299,998 Project Grant award was provided by the U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) to the University of Nebraska Medical Center (UNMC). The award will support a 2-year research project from July 2024 to July 2026 entitled "VAP-1 AND METHYLGLYOXAL AS NOVEL TARGETS IN LUPUS NEPHRITIS". Through this funding, UNMC will conduct innovative biomedical research to investigate new treatment approaches for lupus nephritis, a...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program provides $300,000.00 in funding to Duke University to conduct research on the "COMPLEMENT-ACTIVATING PROPERTIES OF ANTI-SM/RNP ANTIBODIES IN SLE". The research aims to investigate innovative approaches to disease prevention, diagnosis, treatment, and management, with a particular emphasis on conditions relevant to military personnel and veterans. The...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $299,937.00 to The Feinstein Institutes For Medical Research to conduct research on visualizing neural synaptic density in systemic lupus erythematosus (SLE) to better understand mechanisms of brain dysfunction. The award period runs from July 15, 2024 to July 14, 2026. The Feinstein Institutes, a non-profit research organization, will utilize this...
This Project Grant award, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports a multi-PI research project focused on identifying the upstream pathways that drive the chronic production of type I interferons in systemic lupus erythematosus (SLE). The $3,072,631 award supports a collaborative research effort between the University of Washington, Rockefeller University, and the University of...
The University of Houston was awarded a $750,000 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research into interleukin-15 (IL-15) in lupus from September 30, 2021 through September 29, 2025. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military and public health care through innovative...
The Board of Regents of the University of Nebraska received a $300,000 Project Grant award from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant funds research on "SOMATIC MUTATIONS IN NON-IG LOCI IN AUTOREACTIVE B CELLS AS DRIVERS OF LUPUS PATHOGENESIS AND DISEASE HETEROGENEITY" being conducted at the University of Nebraska Medical Center in Omaha, Nebraska from July 1, 2023 through June 30, 2025. The Military...